Pramana
We imagine a world where children feel safe to sleep
A safe and accessible oral prevention for Hypolglycemia would achieve that
The Market
The unmet opportunity - Pramana's commitment
625,000,000
People will suffer from diabetes by 2024
490,000,000,000
Dollars in Global Healthcare Expenditures of Diabetes by 2030
100,000,000
People affected by hypoglycemia right now
Unmet Needs
The highest unmet need in the Diabetes space is the inability to maintain good long term glycemic control. By 2040 it is estimated that 625 million people will be suffering from Diabetes. One of the biggest fears for a significant percentage of people living with Diabetes is hypoglycemia and the associated risks. Hypoglycemia affects over 100 million people with Diabetes. This comprises 90% of the T1D and 25% of the T2D population and includes a significant pediatric population. We are committed to providing a prevention with meaningful long term benefit.
Driven by Opportunity
Global Healthcare Expenditures of Diabetes is expected to reach $490 Billion by 2030, with 537 million people with Diabetes that would benefit from an oral once daily prevention for Hypoglycemia. Our Team is focused on providing meaningful therapies for patients suffering from Diabetes and associated immunometabolic disorders.
The opportunity for an Oral Preventative Treatment for Hypoglycemia is just one of many areas of high unmet medical need associated with Immuno-metabolic disorders. We are committed to addressing this.
The Market
50%
Of people with Diabetes are currently undiagnosed
1
Person dies of Diabetes every 5 minutes
537,000,000
People currently live with diabetes
Pramana